A Study in Healthy People to Test How Well Repeated Doses of BI 3032950 Are Tolerated
Clinical trial NCT05985200 · COMPLETED
Trial details
- NCT number
- NCT05985200
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-15
- Primary completion
- 2024-08-19
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.